Biotech Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2026 November 5, 2026
Biotech Curis to Report Third Quarter 2026 Financial and Operating Results and Host Conference Call and Webcast on November 12, 2026 November 5, 2026
Biotech MHRA approves Pharming’s Joenja® (leniolisib) as first treatment specifically for children with APDS in the U.K. November 5, 2026
Biotech Co-Diagnostics Announces Updated Third Quarter 2026 Earnings Release Date and Webcast November 5, 2026
Biotech Rakovina Therapeutics to Present Brain-Penetrant ATR Inhibitor Data at the 31st Society for Neuro-Oncology Annual Meeting November 5, 2026
Biotech Caris Life Sciences Reports Third Quarter 2026 Financial Results and Increases 2026 Revenue Guidance November 5, 2026